Immortal Time-Bias–Corrected Survival of Highly Sensitized Patients and HLA-desensitized Kidney Transplant Recipients-Reference-Cited by-同舟云学术

Immortal Time-Bias–Corrected Survival of Highly Sensitized Patients and HLA-desensitized Kidney Transplant Recipients

Published:2021-10 Issue:10 Volume:6 Page:2629-2638
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Noble Johan^ORCID,Metzger Antoine,Daligault Melanie,Chevallier Eloi,Bugnazet Mathilde,Bardy Beatrice,Naciri Bennani Hamza,Terrier Nicolas,Fiard Gaelle,Franquet Quentin,Janbon Benedicte,Masson Dominique,Giovannini Diane,Malvezzi Paolo,Jouve Thomas,Rostaing Lionel^ORCID

Publisher

Elsevier BV

Subject

Nephrology

Reference27 articles.

1. Worldwide access to treatment for end-stage kidney disease: a systematic review;Liyanage;Lancet,2015

2. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant;Wolfe;N Engl J Med,1999

3. How do highly sensitized patients get kidney transplants in the United States? Trends over the last decade;Jackson;Am J Transplant,2020

4. UK Renal Registry 16th annual report: chapter 4 demography of patients waitlisted for renal transplantation in the UK: national and centre-specific analyses;Pruthi;Nephron Clin Pract,2013

5. The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome;Claas;Transplantation,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series;Transplantation Direct;2024-08-29

2. CAR T-cell therapy—paving the way for sensitized kidney transplant patients;Kidney International;2024-05

3. Imlifidase Desensitization in HLA-incompatible Kidney Transplantation: Finding the Sweet Spot;Transplantation;2024-01-19

4. Daratumumab for antibody-mediated rejection: Is it time to target the real culprit?;American Journal of Transplantation;2023-12

5. Desensitization in Solid Organ Transplantation;Biomedical Engineering;2023-11-23